*  Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome - Full Text View -...
Myelodysplastic Syndrome-003 Study Investigators. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N ... Syndrome. Myelodysplastic Syndromes. Preleukemia. Disease. Pathologic Processes. Bone Marrow Diseases. Hematologic Diseases. ... Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome (SINTRA-REV). This study is ... Period until the progression of myelodysplastic syndrome [ Time Frame: 6 years (study treatment and follow up) ]. To assess if ...
  https://clinicaltrials.gov/show/NCT01243476
*  De Novo Myelodysplastic Syndromes - DrugBank
This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with funding from the federal government. Maintenance, support, and commercial licensing is provided by OMx Personal Health Analytics, Inc. Designed by Educe Design & Innovation Inc. ...
  https://www.drugbank.ca/indications/DBCOND0036075
*  Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes |...
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. ... syndrome (4.5% and 13.6%, respectively), suggesting a role in disease progression in del(5q) myelodysplastic syndromes. Fifty- ... Quality of the myelodysplastic syndrome del(5q) MiSeq sample run. The number of clusters that passed the quality filter was ... del(5q) myelodysplastic syndrome cohort. Samples from 43 untreated MDS cases harboring a del(5q) were selected for mutational ...
  http://www.haematologica.org/content/98/12/1856
*  NCCN Quick Guide™ | Myelodysplastic Syndromes
NCCN Quick Guide™ , Myelodysplastic Syndromes. 1 of 2 NCCN QUICK GUIDE tm Myelodysplastic Syndromes, 2018 This NCCNQUICK GUIDE ... NCCN Guidelines for Patients ® Page Number Ü NCCN GUIDELINES FOR PATIENTS ® NCCN QUICK GUIDE tm Myelodysplastic Syndromes 2018 ... myelodysplastic syndromes)? MDS is a group of cancers that affect blood cells in the bloodstream and bone marrow. In MDS, the ... Myelodysplastic Syndromes . T hese guidelines explain which tests and treatments are recommended by experts in cancer. To view ...
  https://www.nccn.org/patients/guidelines/quick_guides/mds/index.html
*  Printable - Myelodysplastic Syndrome Unclassifiable - Surgical Pathology Criteria - Stanford University School of Medicine
Myelodysplastic Syndrome, Unclassifiable. Definition. *Myelodysplastic syndromes that do not meet criteria of a specific WHO ... Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome ... Myelodysplastic / myeloproliferative neoplasm with isolated isochromosome 17q. Myelodysplastic Syndromes (MDS). *Refractory ... Myelodysplastic Syndromes. Circulating Blasts. Marrow Blasts. Ring Sideroblasts. Dysplastic Lineages. Cytopenias. RCUD. ,1%. ,5 ...
  http://surgpathcriteria.stanford.edu/mdsmps/unclassifiable-myelodysplastic-syndrome/printable.html
*  Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a...
Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a ...
  http://www.aamds.org/node/2583
*  Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome - Full Text View - ClinicalTrials.gov
Syndrome. Myelodysplastic Syndromes. Preleukemia. Disease. Pathologic Processes. Bone Marrow Diseases. Hematologic Diseases. ... MedlinePlus related topics: Myelodysplastic Syndromes Genetic and Rare Diseases Information Center resources: Myelodysplastic ... Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome. This study has been withdrawn prior to ... DISEASE CHARACTERISTICS: Histologically confirmed primary myelodysplastic syndrome (MDS) with greater than 10% bone marrow ...
  https://clinicaltrials.gov/ct2/show/NCT00003984
*  Myelodysplastic Syndromes MDS - What Is It, Symptoms, Causes | Lifescript.com
Learn about myelodysplastic syndromes mds symptoms, myelodysplastic syndromes mds causes, diagnosis, and more. ... Understanding myelodysplastic syndromes: a patient handbook. Patient information page. The Myelodysplastic Syndromes Foundation ... Myelodysplastic syndromes (MDS) are a group of diseases that involve dysfunction of the bone marrow. Bone marrow is the tissue ... Myelodysplastic syndromes: a review for patients, families, friends, and healthcare professionals. Patient information page. ...
  http://www.lifescript.com/health/centers/cancer/related_conditions/myelodysplastic_syndromes_mds
*  Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome...
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome ... Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome ... Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome ... of myelodysplastic syndrome reviewed the morphological features of bone marrows from all subtypes of myelodysplastic syndrome ...
  http://www.haematologica.org/content/93/11/1712.full
*  Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or...
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or ... Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or ... Azacitidine in Combination With Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic ... Patients must have morphologically confirmed diagnosis of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia ( ...
  https://clinicaltrials.gov/ct2/show/record/NCT01522976?term=NCT01522976&rank=1
*  Best Myelodysplastic Syndrome Doctor in Delhi NCR, Myelodysplastic Syndrome Doctors | Credihealth
Get guidance from medical experts to select myelodysplastic syndrome specialist in Delhi NCR from trusted hospitals - ... Find the best myelodysplastic syndrome doctors in Delhi NCR. ... Best doctors for myelodysplastic-syndrome in Delhi NCR List of ... Need help in choosing myelodysplastic syndrome doctor in Delhi NCR? The medical expert will guide you for all hospital needs ... Need help in choosing myelodysplastic syndrome doctor in Delhi NCR? The medical expert will guide you for all hospital needs ...
  https://www.credihealth.com/doctors/delhi-ncr/myelodysplastic-syndrome
*  Azacitidine in lower-risk myelodysplastic syndromes. | Aplastic Anemia and MDS International Foundation
... compared with conventional care regimens in patients with higher-risk myelodysplastic syndromes (MDS). Here, we review ... compared with conventional care regimens in patients with higher-risk myelodysplastic syndromes (MDS). Here, we review ...
  http://www.aamds.org/node/457
*  Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
The primary objective of this study is to compare overall survival (OS) in patients receiving ON 01910.Na + best supportive care (BSC) to OS of patients
  http://www.knowcancer.com/cancer-trials/NCT01241500/
*  Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain...
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders characterized by bone marrow failure and a ... The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders characterized by bone marrow failure and a ... Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain ...
  http://www.aamds.org/node/2534
*  A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes - Full Text View - ClinicalTrials.gov
Syndrome. Myelodysplastic Syndromes. Preleukemia. Disease. Pathologic Processes. Bone Marrow Diseases. Hematologic Diseases. ... MedlinePlus related topics: Myelodysplastic Syndromes Genetic and Rare Diseases Information Center resources: Myelodysplastic ... A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes. The safety and scientific validity ... This is a Phase 1 study during which patients with low or intermediate-1 risk myelodysplastic syndromes (MDS) will receive ...
  https://clinicaltrials.gov/show/NCT01496495
*  Myelodysplastic syndromes | Aplastic Anemia and MDS International Foundation
15% of cases occur after chemotherapy or radiotherapy for a previous cancer; the syndromes are most common in elderly people. ... Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by ineffective haemopoiesis leading to blood ... Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by ineffective haemopoiesis leading to blood ... Treatment of patients with lower-risk myelodysplastic syndromes, especially for anaemia, includes growth factors, lenalidomide ...
  http://www.aamds.org/node/2509
*  Emerging immunosuppressive drugs in myelodysplastic syndromes | Aplastic Anemia and MDS International Foundation
Myelodysplastic syndromes (MDS) are characterized by dysplastic morphologic features and ineffective hematopoiesis. ... Myelodysplastic syndromes (MDS) are characterized by dysplastic morphologic features and ineffective hematopoiesis. ...
  http://www.aamds.org/node/1628
*  StudyPages - Response-Based Chemotherapy to treat newly diagnosed Acute Myeloid Leukemia /Myelodysplastic Syndrome patients...
This study looks at response-based chemotherapy in treating newly diagnosed acute myeloid leukemia or myelodysplastic syndrome ... Response-based treatment may be effective in treating acute myeloid leukemia or myelodysplastic syndrome in younger patients ... Response-Based Chemotherapy to treat newly diagnosed Acute Myeloid Leukemia /Myelodysplastic Syndrome patients with Down ... marrow blasts are eligible if they meet the criteria for a diagnosis of myelodysplastic syndrome (MDS). - Patients with a ...
  https://studypages.com/s/response-based-chemotherapy-to-treat-newly-diagnosed-acute-myeloid-leukemia-myelodysplastic-syndrome-patients-with-down-syndrome-466319/?ref=gallery
*  Refractory cytopenia of childhood - Wikipedia
Refractory cytopenia of childhood (RCC) is a subgroup of myelodysplastic syndrome (MDS), having been added to the World Health ... Niemeyer, C. M.; Baumann, I (2011). "Classification of childhood aplastic anemia and myelodysplastic syndrome". Hematology. ...
  https://en.wikipedia.org/wiki/Refractory_cytopenia_of_childhood
*  Myelodysplastic Syndromes
... are worried about developing myelodysplastic syndrome, have just been diagnosed, are going through treatment, or are trying to ... Myelodysplastic Syndromes. If you have a myelodysplastic syndrome or are close to someone who does, knowing what to expect can ... If You Have Myelodysplastic Syndrome (MDS). If you or someone you know has just been diagnosed with myelodysplastic syndrome, ... Treating Myelodysplastic Syndromes If you are facing a myelodysplastic syndrome, we can help you learn about the treatment ...
  https://www.cancer.org/cancer/myelodysplastic-syndrome.html
*  Molecular Pathogenesis of Myelodysplastic Syndromes | SpringerLink
Myelodysplastic syndromes (MDSs) are a collection of clonal stem cell hematopoietic disorders that are characterized by ... bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia ... Angiogenesis in myelodysplastic syndromes. Br J Cancer. 1999;81:1398-1401.PubMedCrossRefGoogle Scholar ... Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Eng J Med. 2006;355:1456-1465.CrossRefGoogle ...
  https://link.springer.com/chapter/10.1007/978-1-4419-5698-9_33
*  Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes Our MDS center headed by Dr Amit Verma is recognized as a national "center of excellence" by the MDS ... Myelodysplastic Syndromes (MDS) are diseases of the blood and bone marrow, characterized by low blood counts. Normally, the ... Foundation and offers a variety of treatments and clinical trials for patients with Myelodysplastic syndromes. ... "myelo") usually look abnormal (or "dysplastic"), hence the name "Myelodysplastic" Syndromes. ...
  http://www.montefiore.org/myelodysplastic-syndromes-mds
*  NCCN Guidelines for Patients® | Myelodysplastic Syndromes
NCCN Guidelines for Patients® , Myelodysplastic Syndromes. 42 NCCN Guidelines for Patients ® : Myelodysplastic Syndromes, 2018 ...
  https://www.nccn.org/patients/guidelines/mds/44/
*  NCCN Guidelines for Patients® | Myelodysplastic Syndromes
NCCN Guidelines for Patients® , Myelodysplastic Syndromes. 2 NCCN Guidelines for Patients ® : Myelodysplastic Syndromes, 2018 ... Based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) Myelodysplastic Syndromes (Version 1.2018). ...
  https://www.nccn.org/patients/guidelines/mds/4/
*  Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body...
Myelodysplastic Syndromes. Preleukemia. Lymphoma, Non-Hodgkin. Leukemia, Lymphoid. Precursor Cell Lymphoblastic Leukemia- ... Myelodysplastic syndromes/myeloproliferative disorders (MDS/MPD) - must have received previous myelosuppressive chemotherapy or ... Myelodysplastic Syndromes Chronic Myeloid Leukemia Homologous Wasting Disease Mycosis Fungoides Lymphoma, Large-cell Anaplastic ... Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Phase Chronic Myelogenous ...
  https://clinicaltrials.gov/ct2/show/NCT00089011?recr=Open&cond=%22Mycoses%22&rank=3